A comparison study of the therapeutic effect of " topical steroid" and "honey plus coffee" on Oral Mucositis after chemotherapy and/or radiotherapy

INTERVENTION: Intervention 1: Intervention1 : 500 ml solution containing 20 ampoules that each one contained 8 mg betamethasone" The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week. Intervention 2: Intervention2 : 500 ml solution containing 300gram honey and 20 gram coffee; The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week. Intervention 3: Intervention3: 500 ml solution containing placebo" The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week. Intervention1 : 500 ml solution containing 20 ampoules that each one contained 8 mg betamethasone" The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week Intervention2 : 500 ml solution containing 300gram honey and 20 gram coffee; The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week Intervention3: 500 ml solution containing placebo" The participants are told to sip 10 cc of the prescribed product, and then swallow it every 3 hours for one week Placebo Treatment ‐ Drugs Treatment ‐ Other CONDITION: K13.7 Other and unspecified lesions of oral mucosa. ; K13.7 PRIMARY OUTCOME: Oral Mucositis after chemotherapy and/or radiotherapy. Timepoint: Before and after the treatment and also one week after the treatment. Method of measurement: Oral lesions: normal (0), low (+), moderate (++), and severe (+++). SECONDARY OUTCOME: Pain. Timepoint: Before and after the treatment and also one week after the treatment. Method of measurement: Normal (0), low (+), moderate (++), and severe (+++). INCLUSION CRITERIA: INCLUSION CRITERIA: Oral Mucositis after chemotherapy and/or radiotherapy /age between 15 and 80 years. Exclusion criteria: Out of this age range ‐ presence of other systemic disease and gastrointestinal disorders.